Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

Posts by tag

Beta blocker

16 posts
  • This content is machine translated Hypertrophic cardiomyopathies (HCM)

How do myosin inhibitors perform in different HCM phenotypes?

Cardiac myosin inhibitors have been developed as a targeted therapeutic option for modulating sarcomere function. While in clinical trials in obstructive hypertrophic cardiomyopathy they brought about a greater improvement in...…
View Post
  • 5 min
  • This content is machine translated Heart failure: combination of four as "Guideline-Directed Medical Therapy"

Standard established at HFrEF with individual nuances

The modern treatment of heart failure is characterized by early intervention, multidimensional care and extended therapy options. Around half of all heart failure patients have a reduced left ventricular ejection...…
View Post
  • 4 min
  • This content is machine translated Heart failure

Gradually expand drug therapy!

Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable...…
View Post
  • 5 min
  • This content is machine translated Heart failure and type 2 diabetes

SGLT-2-i now recommended for the entire LVEF spectrum

Based on data from large clinical trials, it is currently recommended that all patients with diabetes and chronic heart failure – regardless of left ventricular ejection fraction – are treated…
View Post
  • 6 min
  • This content is machine translated Cardiac arrhythmias

Atrial fibrillation – what do current guidelines say?

Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significantly increased mortality and morbidity. Therefore, timely diagnostic and therapeutic measures are required. The current ESC guidelines…
View Post
  • 5 min
  • This content is machine translated Heart failure

Pharmacotherapy in HFrEF and HFmrEF – Combination of four as gold standard.

Important therapeutic goals in chronic heart failure are to improve quality of life and to reduce the risk of hospitalization and mortality. According to current evidence, guideline-based therapy with the…
View Post
  • 9 min
  • This content is machine translated Catecholaminergic polymorphic ventricular tachycardia.

Rare functional disorder of the structurally healthy heart muscle

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare ion channel disease without macroscopically detectable structural cardiopathy. It occurs exclusively in childhood and adolescence and has a high mortality if untreated.…
View Post
  • 15 min
  • This content is machine translated Causes and medication

Arterial hypertension and heart failure

Inadequately treated arterial hypertension over many years usually leads to heart failure. It is not at all surprising that the onset of heart failure can be delayed by treating blood…
View Post
  • 6 min
  • This content is machine translated After the heart attack

What medication does the patient need?

Heart attack patients should receive aspirin 100 mg and the maximum tolerated statin dose for life. Regardless of the type of revascularization, all myocardial infarction patients should take a P2Y12 inhibitor…
View Post
  • 5 min
  • This content is machine translated Eye pressure measurement is one of the most important preventive examinations

Glaucoma – what does the family doctor need to know about it?

A detailed ophthalmologic examination with eye pressure measurement should be performed in everyone from about the age of 40 (depending on the risk profile). Adherence and persistence of patients with…
View Post
  • 8 min
  • This content is machine translated Heart failure update

Which drugs for which patients?

The new guidelines for the diagnosis and treatment of heart failure were presented at this year’s congress of the European Society of Cardiology at the end of May. The new…
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 2
    Minimally invasive – the quiet triumph of modern heart surgery
  • 3
    HPV prevention, screening innovation and sentinel lymph node biopsy
  • 4
    Clinical care from birth to adulthood
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.